
Ritlecitinib, an investigational covalent kinase inhibitor, achieved its primary endpoint and demonstrated statistically significant efficacy compared to placebo in treating alopecia areata.

Ritlecitinib, an investigational covalent kinase inhibitor, achieved its primary endpoint and demonstrated statistically significant efficacy compared to placebo in treating alopecia areata.

Shino Bay Aguilera, DO, reflects on his keynote address highlighting diversity and wellness in aesthetic medicine at Aesthetics Biomedical’s “Perspectives: The Evolution of Aesthetics” symposium.

AbbVie and Calico Life Sciences have extended their collaboration for the research, development, and commercialization of new treatments focused on age and age-related diseases.

Take a look behind the scenes at the Aesthetics Biomedical's "Perspectives: The Evolution of Aesthetics" symposium held July 24th in Orlando, Florida.

This week, consumer magazines highlight the big business of veneers, how to protect tattoos from the sun, and more.

This week in aesthetics, we highlight Aesthetics Biomedical’s Perspectives symposium, this month’s “Meet the Aesthetic Expert” column, and more.

In this month’s “Meet the Aesthetic Expert” column, Will Kirby, DO, FAOCD, talks with Edrice Simmons, senior vice president for US brands for Allergan Aesthetics, an AbbVie company, about entering the aesthetics industry, innovation, and implementing approachable and representative marketing campaigns.

Cytrellis announced that the FDA has cleared the ellacor system to the treatment of moderate to severe wrinkles.

Christopher Bunick, MD, PhD, provides an update on benzene contamination in sunscreen, including a recent recall from Johnson & Johnson.

BioPhotas announces the new addition to their Celluma light therapy device line, Celluma RESTORE, for the treatment of hair loss, aging skin, and general pain.

This week, consumer magazines highlight hormone testing as the next big skin care trend, barely-there Botox, and more.

A group of expert panelists gathered to discuss how social media can benefit your practice and how to best use it to your advantage.

Victor Ross, MD, board-certified dermatologist and dermatologic surgeon in San Diego, California, spoke about different technologies available for microneedling and energy-based devices.

Opening the symposium in a circle of sparks and salsa dancing, Shino Bay Aguilera, DO, talks the importance of diversity and wellness in aesthetics.

This week in aesthetics, we highlight 10 tips to jump start the practice post-COVID-19, Alma Hybrid laser’s FDA 510(k) clearance, and more.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explores the world of eyebrows, including microblading, grooming, and shape.

The Aesthetic Everything Awards names Alan J. Bauman, MD, ABHRS, IAHRS, FISHRS as "#1 Top Hair Restoration Surgeon" for the fifth year in a row.

Allergan Aesthetics partners with Girls Inc. for the third year in a row, debuting a nationwide mentoring initiative.

The European Wellness Academy partners with China’s provincial government to advance education in biological regenerative medicine.

Alma today announces the FDA clearance of its Alma Hybrid combination platform, which includes an ablative 10,600 nm (CO2) laser and nonablative 1570 nm laser for skin resurfacing.



This week, consumer magazines highlight Botox brow lifts, the Johnson & Johnson recall of 5 aerosol sunscreen brands with benzene traces, and more.

This week in aesthetics, we highlight this month’s "Meet the Aesthetic Expert" column with Morgan Wolf, DNP, FNP-BC, AGNP, Johnson & Johnson recalls 5 aerosol sunscreen brands with benzene traces, and more.

The American Academy of Facial Plastic and Reconstructive Surgery’s president Paul Carniol, MD, debunks 3 common misconceptions about facelifts.